Keryx Biopharma (KERX) Files $100M Mixed Securities Shelf
Keryx Biopharma (Nasdaq: KERX) filed for a $100 million mixed securities shelf.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corvex Management Cuts Signet Jewelers (SIG) Stake in Half
- Jefferson Capital Interests (JCAP) Announces $50M Common Stock Offering
- Jaguar Animal Health (JAGX) Files 6.67M Common Stock Shelf for Selling Shareholders
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!